Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(20 sites)
Spain
Hospital General de Alicante, Alicante, Alicante Hospital Virgen de la Macarena, Seville, Andalusia Hospital Virgen del Rocío, Seville, Andalusia Hospital Son Espases, Palma de Mallorca, Balearic Islands Hospital del Mar, Barcelona, Barcelona Hospital Clinic i Provincial de Barcelona, Barcelona, Barcelona Hospital Sant Pau, Barcelona, Barcelona Hospital Bellvitge, Barcelona, Barcelona Parc Taulí Hospital Universitari, Sabadell, Barcelona Hospital Mútua de Terrassa, Terrassa, Barcelona Hospital Universitario de Cruces, Barakaldo, Bizcaia Hospital Universitario Marqués de Valdecilla, Santander, Cantabria Hospital Universitario de Donostia, Donostia / San Sebastian, Guipuzcoa Hospital San Pedro, Logroño, La Rioja Hospital General Universitario Gregorio Marañón, Madrid, Madrid Hospital Ramón y Cajal, Madrid, Madrid Hospital Universitario La Paz, Madrid, Madrid Hospital Virgen de Arrixaca, El Palmar, Murcia Hospital universitario de Canarias, San Cristóbal de La Laguna, Santa Cruz de Tenerife Hospital Universitari i Politècnic La Fe, Valencia, València